NMDA receptors in the nucleus accumbens modulate intravenous cocaine but not heroin self-administration in the rat.

Luigi Pulvirenti , Rafael Maldonado-Lopez , George F. Koob
Brain Research 594 ( 2) 327 -330

118
1992
Phosphorus-containing peptides as mixed inhibitors of endopeptidase 3.4.24.15 and 3.4.24.16: effect on neurotensin degradation in vitro and in vivo

Bruno Vincent , Vincent Dive , Athanasios Yiotakis , Claire Smadja
British Journal of Pharmacology 115 ( 6) 1053 -1063

28
1995
Rimonabant en el tratamiento de la diabetes tipo 2: nuevas evidencias

M. García-Vitoria , Rafael Maldonado López
Avances en Diabetología 23 ( 6) 399 -412

2007
Cannabinoides y control del dolor: estudios en modelos animales

Fernando Berrendero Diaz , Rafael Maldonado López
Dolor: Investigación, clínica & terapéutica 20 ( 4) 179 -186

2005
Adicción a los cannabinoides: modelos de comportamiento y correlaciones neurales

Fernando Antonio Rodríguez de Fonseca , Rafael Maldonado López
RET: revista de toxicomanías ( 43) 3 -10

2005
Cholecystokinin B antagonists strongly potentiate antinociception mediated by endogenous enkephalins.

M C Fournie-Zaluski , O Valverde , B P Roques , R Maldonado
Journal of Pharmacology and Experimental Therapeutics 270 ( 1) 77 -88

88
1994
Naloxone-induced withdrawal syndrome after administration of selective opioid agonists or after activation of the endogenous enkephalinergic system.

J Feger , B P Roques , R Maldonado , G Waksman
Progress in Clinical and Biological Research 328 531 -534

1990
Mécanisme d'action de la morphine

B Kieffer , H Matthes , R Maldonado
M S-medecine Sciences 13 ( 2) 232 -235

1
1997
Genetic and pharmacological approaches to evaluate the interaction between the cannabinoid and cholinergic systems in cognitive processes.

S A Bura , A Castañé , C Ledent , O Valverde
British Journal of Pharmacology 150 ( 6) 758 -765

19
2007
The absence of VGLUT3 predisposes to cocaine abuse by increasing dopamine and glutamate signaling in the nucleus accumbens.

D Y Sakae , F Marti , S Lecca , F Vorspan
Molecular Psychiatry 20 ( 11) 1448 -1459

40
2015
The α3β4* nicotinic ACh receptor subtype mediates physical dependence to morphine: mouse and human studies

P P Muldoon , K J Jackson , E Perez , J L Harenza
British Journal of Pharmacology 171 ( 16) 3845 -3857

28
2014
Pharmacological properties of S1RA, a new sigma-1 receptor antagonist that inhibits neuropathic pain and activity-induced spinal sensitization.

L Romero , D Zamanillo , X Nadal , R Sánchez-Arroyos
British Journal of Pharmacology 166 ( 8) 2289 -2306

126
2012
Involvement of neuropeptide FF receptors in neuroadaptive responses to acute and chronic opiate treatments.

K Elhabazi , JM Trigo , C Mollereau , L Moulédous
British Journal of Pharmacology 165 ( 2) 424 -435

54
2012
Lack of CB1 cannabinoid receptors modifies nicotine behavioural responses, but not nicotine abstinence.

A Castañé , E Valjent , C Ledent , M Parmentier
Neuropharmacology 43 ( 5) 857 -867

217
2002
FAAH deficiency promotes energy storage and enhances the motivation for food

C Touriño , F Oveisi , J Lockney , D Piomelli
International Journal of Obesity 34 ( 3) 557 -568

61
2010
A cognitive protection peptide for cannabis-based pain treatment

M Gallo , S Defaus , E Moreno , B Alvarez-Perez
17 Naples Workshop on Bioactive Peptides 60 -60

2022
FAAH deficiency promotes energy storage and enhances the motivation for food

C Tourino , F Oveisi , J Lockney , D Piomelli
International Journal of Obesity 36 ( 3) 477 -478

2012
Erratum: FAAH deficiency promotes energy storage and enhances the motivation for food

C Touriño , F Oveisi , J Lockney , D Piomelli
International Journal of Obesity 36 ( 3) 477 -477

2012